Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04508777 · ClinicalTrials.gov registry record
COVID SAFE: COVID-19 Screening Assessment for Exposure
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 1,759
- Enrollment target
NCT04508777: Completed study, sponsored by University of Pennsylvania.
NCT04508777 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 1,759 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04508777 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 1,759 participants
- Enrollment target
Study Summary
In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. This study will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing.
Primary Outcome
The rate of compliance with saliva-based testing
Interventions
- BEHAVIORAL Saliva-based testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,759 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2021-06-23 |
What the finished NCT04508777 record still lists
NCT04508777 is an observational study that tracks outcomes without assigning an intervention. Its 1,759 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Saliva-based testing is the first listed.
NCT04508777 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04508777 about?
NCT04508777 is a clinical study titled "COVID SAFE: COVID-19 Screening Assessment for Exposure". In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. This study will evaluate the imple...
What is the current status of trial NCT04508777?
This trial is currently completed. The enrollment target is 1,759 participants. The study started on 2020-09-09. Estimated completion is 2021-06-23.
What interventions are being tested in trial NCT04508777?
The interventions under investigation include: Saliva-based testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04508777?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI